Search Results - "Compter, Inge"

Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validation.

Authors: Weis, Joachim Wirtz, Markus A. Tomaszewski, Krzysztof A. et al.

Source: Psycho-Oncology. Aug2019, Vol. 28 Issue 8, p1753-1761. 9p. 4 Charts.

Subjects: Cancer fatigue, Quality of life, Anxiety sensitivity

Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial.

Authors: Compter, Inge Eekers, Danielle B. P. Hoeben, Ann et al.

Source: Autophagy. September 2021, Vol. 17 Issue 9, p2604-2612. 9p.

Deciphering the glioblastoma phenotype by computed tomography radiomics.

Authors: Compter, Inge Verduin, Maikel Shi, Zhenwei et al.

Source: Radiotherapy & Oncology. Jul2021, Vol. 160, p132-139. 8p.

Subjects: Computed tomography, Radiomics, Brain tumors, Phenotypes, Overall survival, Prognosis

Trends in radiotherapy fractionation for bone metastases: a multi-center study of practice patterns before, during, and after COVID-19.

Authors: Slotman, Ellis Fransen, Heidi P. Gal, Roxanne et al.

Source: Radiation Oncology Journal. Jun2026, Vol. 44 Issue 2, p107-116. 10p.

Predictors of Growth of Vestibular Schwannoma After Gamma Knife Treatment: A Systematic Review.

Authors: Yang, Cheng Alvarado, Daniel Ravindran, Pawan Kishore et al.

Source: Cancers. Jun2025, Vol. 17 Issue 12, p1993. 12p.

Deep Learning for Automated Ventricle and Periventricular Space Segmentation on CT and T1CE MRI in Neuro-Oncology Patients.

Authors: Wubbels, Mart Ribeiro, Marvin Wolterink, Jelmer M. et al.

Source: Cancers. May2025, Vol. 17 Issue 10, p1598. 21p.

Impact of clinical target volume margin reduction in glioblastoma patients treated with concurrent chemoradiation.

Authors: Perri, Dario Di Hofstede, David Hartgerink, Dianne et al.

Source: Neuro-Oncology Practice. Jun2024, Vol. 11 Issue 3, p249-254. 6p.

Skull-Base Chondrosarcoma: A Systematic Review of the Role of Postoperative Radiotherapy.

Authors: Ravindran, Pawan Kishore Keizer, Max E. Kunst, Henricus P. M. et al.

Source: Cancers. Mar2024, Vol. 16 Issue 5, p856. 22p.

The Use of 18 F-FET-PET-MRI in Neuro-Oncology: The Best of Both Worlds—A Narrative Review.

Authors: van de Weijer, Tineke Broen, Martijn P. G. Moonen, Rik P. M. et al.

Source: Diagnostics (2075-4418). May2022, Vol. 12 Issue 5, pN.PAG-N.PAG. 12p.

Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma.

Authors: Verduin, Maikel Primakov, Sergey Compter, Inge et al.

Source: Cancers. 2/15/2021, Vol. 13 Issue 4, p722-722. 1p.

216: Prediction of serum biomarkers for cognitive decline after PCI in lung cancer: an exploratory study.

Authors: Zeng, Haiyan Hendriks, Lizza Belderbos, José José et al.

Source: Radiotherapy & Oncology. 2024 Supplement 1, Vol. 194, pS1593-S1596. 4p.

Precisie bestraling voor epilepsie, de PRECISION-trial.

Authors: Zegers, Karen Swinnen, Ans Roumen, Cheryl et al.

Source: Epilepsie, Periodiek voor Professionals. Dec2023, Vol. 22 Issue 4, p18-21. 4p.

Stereotactic radiotherapy on Parkinson's disease induced tremors – a systematic review.

Authors: de Haan, Laura M.M. Demmink, Merel C.L. Zegers, Catharina M.L. et al.

Source: Radiotherapy & Oncology. Jan2026, Vol. 214, pN.PAG-N.PAG. 1p.

Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology.

Authors: Eekers, Daniëlle B.P. Di Perri, Dario Roelofs, Erik et al.

Source: Radiotherapy & Oncology. Jul2021, Vol. 160, p259-265. 7p.

Decision Support Systems in Oncology.

Authors: Walsh, Seán de Jong, Evelyn E.C. van Timmeren, Janna E. et al.

Source: JCO Clinical Cancer Informatics. 2/7/2019, Vol. 3, p1-9. 9p.

Evaluating and reporting LET and RBE-weighted dose in proton therapy for glioma – The Dutch approach.

Authors: Wagenaar, Dirk Habraken, Steven J.M. Rinaldi, Ilaria et al.

Source: Radiotherapy & Oncology. Jan2025, Vol. 202, pN.PAG-N.PAG. 1p.

The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology.

Authors: Eekers, Daniëlle BP in 't Ven, Lieke Roelofs, Erik et al.

Source: Radiotherapy & Oncology. Jul2018, Vol. 128 Issue 1, p37-43. 7p.

EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition.

Authors: Jutten, Barry Keulers, Tom G. Peeters, Hanneke J. M. et al.

Source: Autophagy. 2018, Vol. 14 Issue 2, p283-295. 13p.

Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.

Authors: Zindler, Jaap D. Jochems, Arthur Lagerwaard, Frank J. et al.

Source: Radiotherapy & Oncology. May2017, Vol. 123 Issue 2, p189-194. 6p.

International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).

Authors: Weis, Joachim Tomaszewski, Krzysztof A. Hammerlid, Eva et al.

Source: JNCI: Journal of the National Cancer Institute. May2017, Vol. 109 Issue 5, p1-8. 8p. 2 Diagrams, 5 Charts.